Showing 5,921 - 5,940 results of 12,750 for search '"therapeutics"', query time: 0.08s Refine Results
  1. 5921

    Statins as Modulators of Regulatory T-Cell Biology by David A. Forero-Peña, Fredy R. S. Gutierrez

    Published 2013-01-01
    “…Hence, strategies oriented towards the therapeutic expansion of Tregs are gaining special attention among biomedical researchers. …”
    Get full text
    Article
  2. 5922

    Advances in personalized gastroenterology and hepatology 2016 by E. Blum Hubert

    Published 2016-08-01
    “…Such data increasingly allow to define the individual disease predisposition or risk and to predict disease prognosis as well as the efficacy of therapeutic strategies in the individual patient (‘personalized medicine’). …”
    Get full text
    Article
  3. 5923

    Semi-Empirical Predictions on the Structure and Properties of ent-Kaurenoic Acid and Derivatives by Jose Isagani B. Janairo, Gerardo C. Janairo, Derrick Ethelbhert C. YU

    Published 2011-01-01
    “…The physicochemical properties of ent- kaurenoic acid model derivatives, which possibly influence its therapeutic application, were calculated. Results revealed that the molecule possess favourable attributes which renders it possible to be considered as a drug lead only that its very hydrophobic nature can result to poor bioavailabilty, low absorption and poor systemic circulation. …”
    Get full text
    Article
  4. 5924

    Contemporary treatment of right ventricular failure by Bibhuti B. Das, MD, Shashi Raj, MD, FAAP, FACC

    Published 2025-02-01
    “…The pathophysiology of RVF involves complex interactions, such as maladaptive hypertrophy, metabolic reprogramming, inflammation, fibrosis, apoptosis, and endothelial dysfunction. Therapeutic strategies are limited for RVF, as basic and clinical research has historically focused mainly on the left ventricle. …”
    Get full text
    Article
  5. 5925

    Interleukin-23 and Th17 Cells in the Control of Gut Inflammation by Ivan Monteleone, Francesco Pallone, Giovanni Monteleone

    Published 2009-01-01
    “…The demonstration that Th17-related cytokines cause pathology in many organs, including the gut, and that expansion and maintenance of Th17 cell responses require the activity of IL-23, a cytokine made in excess in the gut of IBD patients has contributed to elucidate new pathways of intestinal tissue damage as well as to design new therapeutic strategies. In this review, we discuss the available data supporting the role of the IL-23/Th17 axis in the modulation of intestinal tissue inflammation.…”
    Get full text
    Article
  6. 5926

    Combined Pulmonary Fibrosis and Emphysema Syndrome: A New Phenotype within the Spectrum of Smoking-Related Interstitial Lung Disease by Karina Portillo, Josep Morera

    Published 2012-01-01
    “…Currently, there is no consensus about its treatment since those published to date on this issue are limited to well-characterised series of cases; hence, a better understanding of this entity may help in the development of future therapeutic approaches.…”
    Get full text
    Article
  7. 5927

    Current developments in personalized treatment strategies for elderly acute myelogenous leukemia patients by Xueting Hou, Jizhang Bao

    Published 2025-01-01
    “…Acute myelogenous leukemia(AML) is a life-threatening hematologic malignancy that predominantly affects the elderly.Currently, chemotherapy and hematopoietic stem cell transplantation are the primary treatment modalities for AML, though their clinical application is limited in older patients.Recent years have seen the development of novel molecular targeted therapies, such as isocitrate dehydrogenase 1/2 (IDH1/2) and Feline macrophage stimulator-like tyrosine kinase 3 (FLT3) inhibitors, as well as individualized approaches like chimeric antigen receptor T-cell (CAR-T) therapy.However, due to patient heterogeneity and drug resistance, treatment outcomes for elderly AML remain unsatisfactory, underscoring the need for more precise and safer individualized treatment strategies.The combination of chemotherapy with novel targeted or immunotherapies shows promise as a future treatment direction.This research reviews the latest advances in the treatment of elderly AML, with a focus on achieving more individualized and safer therapeutic approaches.…”
    Get full text
    Article
  8. 5928

    Innovative approaches to asthma treatment: harnessing nanoparticle technology by Vanshika Goswami, Kushneet Kaur Sodhi, Chandra Kant Singh

    Published 2025-02-01
    “…Nanoparticle drug delivery systems offer improved therapeutic efficacy compared to conventional administration techniques. …”
    Get full text
    Article
  9. 5929

    Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy by Minni Zhang, Kailin Huang, Qiushi Yin, Xueqin Wu, Mingyue Zhu, Mengsen Li

    Published 2025-01-01
    “…As the efficacy of immunotherapy mainly depends on the spatial heterogeneity of the tumor immune microenvironment, it is necessary to elucidate the crosstalk between the composition of the liver cancer immune environment, from which potential therapeutic targets can be selected to provide more appropriate individualized treatment programs. …”
    Get full text
    Article
  10. 5930

    Management of Ocular Diseases Using Lutein and Zeaxanthin: What Have We Learned from Experimental Animal Studies? by Chunyan Xue, Richard Rosen, Adrienne Jordan, Dan-Ning Hu

    Published 2015-01-01
    “…The results of these experimental animal studies may provide new preventive and therapeutic procedures for clinical management of various vision-threatening diseases.…”
    Get full text
    Article
  11. 5931

    Clinical Aspects of Trace Elements: Zinc in Human Nutrition – Zinc Deficiency and Toxicity by Michelle M Pluhator, Alan Br Thomson, Richard N Fedorak

    Published 1996-01-01
    “…As the numerous challenges presented by the study of zinc in human nutrition are met, more appropriate recommendations for dietary and therapeutic zinc intake are being made.…”
    Get full text
    Article
  12. 5932
  13. 5933

    Pityriasis rosea: a distinct entity or viral exanthem? by Natalia Dąbrowska, Piotr Węgrzyn, Konstancja Węgrzyn, Gustaw Laskowski, Anna Salińska, Marcin Wasilewski, Julia Skwara, Agnieszka Góra, Maciej Nowicki, Dawid Barański

    Published 2024-11-01
    “…Although the disease is typically not dangerous, it can be a therapeutic challenge, especially when its course is atypical or when it occurs during pregnancy and may pose a risk to the fetus. …”
    Get full text
    Article
  14. 5934

    Cyclic Bicytopenia in a Patient with Shapiro Syndrome by Lindsey E. Roeker, Vinay Gupta, Wilson I. Gonsalves, Alexandra P. Wolanskyj, Naseema Gangat

    Published 2013-01-01
    “…Though accidental and therapeutic hypothermia have been associated with thrombocytopenia, this is, to our knowledge, the first reported case of periodic intrinsic hypothermia causing bicytopenia. …”
    Get full text
    Article
  15. 5935

    Could flavonoid aglycones prevent the absorption of flavonoid glycosides by inhibiting sodium-dependent glucose transporter-1 in the small intestine? by Katrin Sak

    Published 2023-08-01
    “…However, the actual therapeutic use of these phytochemicals is impeded by their low oral bioavailability. …”
    Get full text
    Article
  16. 5936

    Tumor venéreo transmissível canino com resistência quimioterápica e metástase esplênica. Relato de caso by A. P. Duzanski, A. D. Ortiz, H. B. Fêo, M. W. Fonseca, M. M. Flórez, L. T Rodrigues, F. Michelon, N. S. Rocha

    Published 2019-01-01
    “…After the cytological, histological and cytogenetic diagnostic, the primary tumor was still characterized in progression phase and showed low major histocompatibility complex expression MHC (4,4 ± 2% class I e 11 ± 4,1% class II. The dog underwent therapeutic splenectomy and ovariohysterectomy and did not present tumor recurrence within 12 months of clinical follow-up.…”
    Get full text
    Article
  17. 5937

    Molecular Profiling: A Case of ZBTB16-RARA Acute Promyelocytic Leukemia by Stephen E. Langabeer, Lisa Preston, Johanna Kelly, Matt Goodyer, Ezzat Elhassadi, Amjad Hayat

    Published 2017-01-01
    “…Molecular profiling of additional mutations may provide a platform to individualise therapeutic management in patients with this rare form of APL.…”
    Get full text
    Article
  18. 5938

    The Emerging Role of Rab5 in Membrane Receptor Trafficking and Signaling Pathways by Wanqiong Yuan, Chunli Song

    Published 2020-01-01
    “…This review may provide some insights for our future research and novel therapeutic targets for diseases.…”
    Get full text
    Article
  19. 5939

    Clinical Significance and Pathogenic Mechanisms of Long Non-Coding RNA TRPM2-AS in Cancers by Shichen Huang MS, Bowen Li MS, Huanyu Chen MD, Cheng Rong, Zheng Yang MD, Xianqin Zhang PhD

    Published 2025-01-01
    “…The current study highlights the potential of TRPM2-AS as a prognostic and therapeutic target in cancers.…”
    Get full text
    Article
  20. 5940

    Cancer treatment comes to age: from one-size-fits-all to next-generation sequencing (NGS) technologies by Sepideh Parvizpour, Hanieh Beyrampour-Basmenj, Jafar Razmara, Farhad Farhadi, Mohd Shahir Shamsir

    Published 2024-07-01
    “…NGS is expected to lead the transition to precision medicine (PM), where the right therapeutic approach is chosen for each patient based on their characteristics and mutations. …”
    Get full text
    Article